Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Actions

Review
.2014 Dec;22(6):444-9.
doi: 10.1097/MOO.0000000000000112.

Vocal fold paresis: etiology, clinical diagnosis and clinical management

Affiliations
Review

Vocal fold paresis: etiology, clinical diagnosis and clinical management

Sheila V Stager. Curr Opin Otolaryngol Head Neck Surg.2014 Dec.

Abstract

Purpose of review: Recent papers on incidence of unilateral paresis in general and for specific causes; techniques to assist clinical diagnosis; computer and animal modeling leading to new assessment tools; and studies on the effectiveness of clinical management.

Recent findings: There is much interest in being able to assess unilateral paresis in patients both pre and post-thyroidectomy. Because the gold standard for defining the presence of paresis is by laryngeal electromyography, which is not routinely available, much interest has been placed in finding other measures that correlate with electromyographic findings, including use of ultrasound imaging and high-speed videoendoscopy. Paresis is also being seen as an underlying factor in other voice disorders, such as reflux and presence of granulomas. Animal modeling is providing insights into the mechanisms that will help our understanding of vocal fold asymmetry. The development of trial injections to determine if more permanent interventions will provide good outcomes is an important step in good patient care.

Summary: Randomized clinical trials need to be completed to provide level 1 evidence for the efficacy of treatments. Centers that have access to laryngeal electromyography need to lead the way in developing assessment tools and treatment trials for patients with paresis.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources

Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp